Search

Cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed, according to a new study from researchers at UT Southwestern.

An analysis of more than 400 singers who sought treatment at UT Southwestern Medical Center for vocal injuries provides a wealth of data on a topic that’s often considered taboo to discuss in the singing community.

The PGA of America and Omni Hotels & Resorts today announced a new six-year partnership with UT Southwestern Medical Center, naming the hospital as the “Official Healthcare Partner of PGA Frisco.” The relationship will begin in 2023, to coincide with the official opening of PGA Frisco and Omni PGA

Researchers at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center are developing an innovative interface to make the wealth of genomics data from next-generation sequencing visible and actionable in real time for clinicians and researchers.

A team led by UTSW researchers has identified a molecule produced by male parasitic worms called schistosomes that prompts sexual maturity in females of these species.

New research from UT Southwestern suggests that RNA exosomes– the cellular machines that degrade old molecules of RNA – play a key role in the development of B cells, which are critical to the immune system’s ability to protect against infection.

Changes in habits during the pandemic can lead to unexpected health issues with feet and ankles. Orthopedic surgeon Kshitij Manchanda, M.D. at UT Southwestern Orthopaedic Surgery and Sports Medicine has seen an increase in both reported injuries and chronic problems.

UT Southwestern researchers Zhijian “James” Chen, Ph.D., and Sihan Wu, Ph.D., are part of a team that has been awarded a Cancer Grand Challenges grant, a unique award that aims to solve some of cancer’s toughest problems by bringing together global teams with diverse areas of expertise.

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

A compound synthesized by a team led by UT Southwestern scientists kills a range of hard-to-treat cancer types by targeting a previously unexploited vulnerability, a new study reports.